Cannara Biotech Stock Probability of Future OTC Stock Price Finishing Under 0.01

LOVFF Stock  USD 0.52  0.09  20.93%   
Cannara Biotech's future price is the expected price of Cannara Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Cannara Biotech performance during a given time horizon utilizing its historical volatility. Check out Cannara Biotech Backtesting, Cannara Biotech Valuation, Cannara Biotech Correlation, Cannara Biotech Hype Analysis, Cannara Biotech Volatility, Cannara Biotech History as well as Cannara Biotech Performance.
  
Please specify Cannara Biotech's target price for which you would like Cannara Biotech odds to be computed.

Cannara Biotech Target Price Odds to finish below 0.01

The tendency of Cannara OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.01  or more in 90 days
 0.52 90 days 0.01 
near 1
Based on a normal probability distribution, the odds of Cannara Biotech to drop to $ 0.01  or more in 90 days from now is near 1 (This Cannara Biotech probability density function shows the probability of Cannara OTC Stock to fall within a particular range of prices over 90 days) . Probability of Cannara Biotech price to stay between $ 0.01  and its current price of $0.52 at the end of the 90-day period is about 70.0 .
Assuming the 90 days horizon Cannara Biotech has a beta of -1.27. This indicates as returns on its benchmark rise, returns on holding Cannara Biotech are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Cannara Biotech is expected to outperform its benchmark. Additionally Cannara Biotech has an alpha of 0.2194, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cannara Biotech Price Density   
       Price  

Predictive Modules for Cannara Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cannara Biotech. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.030.526.37
Details
Intrinsic
Valuation
LowRealHigh
0.020.426.27
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cannara Biotech. Your research has to be compared to or analyzed against Cannara Biotech's peers to derive any actionable benefits. When done correctly, Cannara Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cannara Biotech.

Cannara Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cannara Biotech is not an exception. The market had few large corrections towards the Cannara Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cannara Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cannara Biotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.22
β
Beta against Dow Jones-1.27
σ
Overall volatility
0.06
Ir
Information ratio -0.0086

Cannara Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cannara Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cannara Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cannara Biotech generated a negative expected return over the last 90 days
Cannara Biotech has high historical volatility and very poor performance
Cannara Biotech has some characteristics of a very speculative penny stock
Cannara Biotech has accumulated about 3.88 M in cash with (6.08 M) of positive cash flow from operations.
Roughly 48.0% of the company outstanding shares are owned by corporate insiders

Cannara Biotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cannara OTC Stock often depends not only on the future outlook of the current and potential Cannara Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cannara Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding877 M

Cannara Biotech Technical Analysis

Cannara Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Cannara OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cannara Biotech. In general, you should focus on analyzing Cannara OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Cannara Biotech Predictive Forecast Models

Cannara Biotech's time-series forecasting models is one of many Cannara Biotech's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cannara Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Cannara Biotech

Checking the ongoing alerts about Cannara Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cannara Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cannara Biotech generated a negative expected return over the last 90 days
Cannara Biotech has high historical volatility and very poor performance
Cannara Biotech has some characteristics of a very speculative penny stock
Cannara Biotech has accumulated about 3.88 M in cash with (6.08 M) of positive cash flow from operations.
Roughly 48.0% of the company outstanding shares are owned by corporate insiders

Other Information on Investing in Cannara OTC Stock

Cannara Biotech financial ratios help investors to determine whether Cannara OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannara with respect to the benefits of owning Cannara Biotech security.